Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Boulder, CO, USA.
Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Crit Care. 2017 Jun 21;21(1):154. doi: 10.1186/s13054-017-1724-z.
Little is known about risk factors associated with out-of-hospital outcomes in survivors of critical illness. We hypothesized that the presence of nucleated red blood cells in patients who survived critical care would be associated with adverse outcomes following hospital discharge.
We performed a two-center observational cohort study of patients treated in medical and surgical intensive care units in Boston, Massachusetts. All data were obtained from the Research Patient Data Registry at Partners HealthCare. We studied 2878 patients, age ≥ 18 years, who received critical care between 2011 and 2015 and survived hospitalization. The exposure of interest was nucleated red blood cells occurring from 2 days prior to 7 days after critical care initiation. The primary outcome was mortality in the 90 days following hospital discharge. Secondary outcome was unplanned 30-day hospital readmission. Adjusted odds ratios were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both nucleated red blood cells and outcome. Adjustment included age, race (white versus nonwhite), gender, Deyo-Charlson Index, patient type (medical versus surgical), sepsis and acute organ failure.
In patients who received critical care and survived hospitalization, the absolute risk of 90-day postdischarge mortality was 5.9%, 11.7%, 15.8% and 21.9% in patients with 0/μl, 1-100/μl, 101-200/μl and more than 200/μl nucleated red blood cells respectively. Nucleated red blood cells were a robust predictor of postdischarge mortality and remained so following multivariable adjustment. The fully adjusted odds of 90-day postdischarge mortality in patients with 1-100/μl, 101-200/μl and more than 200/μl nucleated red blood cells were 1.77 (95% CI, 1.23-2.54), 2.51 (95% CI, 1.36-4.62) and 3.72 (95% CI, 2.16-6.39) respectively, relative to patients without nucleated red blood cells. Further, the presence of nucleated red blood cells is a significant predictor of the odds of unplanned 30-day hospital readmission.
In critically ill patients who survive hospitalization, the presence of nucleated red blood cells is a robust predictor of postdischarge mortality and unplanned hospital readmission.
对于危重病幸存者出院后结局的相关风险因素知之甚少。我们假设,在接受重症监护的患者中存在有核红细胞与出院后的不良结局相关。
我们对马萨诸塞州波士顿的医疗和外科重症监护病房接受治疗的 2878 名年龄≥18 岁的患者进行了一项两中心观察性队列研究。所有数据均来自合作伙伴医疗保健的研究患者数据注册中心。我们研究了 2011 年至 2015 年期间接受重症监护并存活住院的患者。研究的暴露因素为重症监护开始前 2 天至 7 天后出现有核红细胞。主要结局是出院后 90 天内的死亡率。次要结局是 30 天内非计划性再次住院。多变量逻辑回归模型中包含了可能与有核红细胞和结局相互作用的协变量项,以此来估计调整后的比值比。调整包括年龄、种族(白种人或非白种人)、性别、Deyo-Charlson 指数、患者类型(内科或外科)、脓毒症和急性器官衰竭。
在接受重症监护并存活住院的患者中,无核红细胞、有核红细胞 0/μl、有核红细胞 1-100/μl、有核红细胞 101-200/μl 和有核红细胞超过 200/μl 的患者出院后 90 天的绝对死亡率分别为 5.9%、11.7%、15.8%和 21.9%。有核红细胞是出院后死亡率的强有力预测因素,且在多变量调整后仍然如此。有核红细胞 1-100/μl、101-200/μl 和超过 200/μl 的患者出院后 90 天的死亡率的完全调整比值比分别为 1.77(95%置信区间,1.23-2.54)、2.51(95%置信区间,1.36-4.62)和 3.72(95%置信区间,2.16-6.39),与无有核红细胞的患者相比。此外,有核红细胞的存在是预测 30 天内非计划性再次住院的几率的重要指标。
在存活住院的危重病患者中,有核红细胞的存在是出院后死亡率和非计划性住院的强有力预测指标。